首页> 外文期刊>Immunotherapy >Steroid sparing effect of sublingual immunotherapy: real life study in mono/polisensitized children with asthma
【24h】

Steroid sparing effect of sublingual immunotherapy: real life study in mono/polisensitized children with asthma

机译:舌下免疫疗法的类固醇制备效果:哮喘哮喘单索/政府儿童现实生活研究

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Steroid-sparing effect of sublingual immunotherapy (SLIT) in mono/polisensitized asthmatic children were evaluated. Materials and Methods:Children undergoing allergen-specific SLIT between 2010 and 2014 were included. Asthma control and usage/dose of inhaled corticosteroid (ICS) in the previous year was determined. Asthma control without ICS need 6months was defined as ICS avoidance'. Results:90 children (mean +/- SD age 8.92 +/- 4.17years) were enrolled, 56.7% (n=60) being polysensitized. Mono, 2-simultaneous and multiple-pollen-mix allergen SLIT were prescribed in 84.4, 17.8 and 7.8%, respectively. ICS was avoided in 70%, with no significant difference in mono- versus poly-sensitized patients. ICS-avoidance rates in mono-allergen, pollen-mixture and 2-simultaneous-allergen SLIT were 93.6, 83.3 and 73.7%, respectively. Longer-duration SLIT resulted in significantly more ICS-avoidance (p:0.0001). Conclusion: SLIT with mono/multiple-mixed/simultaneous allergens in childhood asthma resulted in retained-avoidance of ICS. Steroid-sparing effect of SLIT in polysensitized children warrants further investigation.
机译:目的:评价舌下免疫疗法(粘接)在单甘露含量免疫疗法(Slit)的类固醇效果评估。材料和方法:包括2010年和2014年间接受过敏原特定裁员的儿童。确定了上一年中吸入皮质类固醇(IC)的哮喘控制和用量/剂量。没有IC的哮喘控制需要6个月被定义为ICS避免“。结果:90名儿童(平均+/-SD年龄8.92 +/- 4.17年)纳入,56.7%(n = 60)是多敏化。单可以分别在84.4,17.8%和7.8%方案中排列的单一,2-同时和多花粉混合物过敏原狭缝。避免了70%的IC,无论多种致敏患者都没有显着差异。单对透过敏原,花粉混合物和2-同时过敏原切片的ICS避免率分别为93.6,83.3和73.7%。较长持续时间的狭缝导致显着的ICS避免(P:0.0001)。结论:用单体/多重混合/同时过敏剂切开儿童哮喘,导致避免IC。狭缝在聚敏感儿童中的类固醇保留效果需要进一步调查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号